TUBA1C

Across TCGA pan-cancer cohorts, TUBA1C Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TUBA1C data layer compared with 29 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TUBA1C Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TUBA1C expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LIHC, and OV are the cancer types where TUBA1C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.439	.020	20	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →
OV	DFS	Median	All	0.132	0.541	.001	6	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TUBA1C–UCEC (DFS)

Open the UCEC breakdown →